Enzalutamide Plus Leuprolide Adds Up to ’Clinically Meaningful’ Benefit in Metastasis-Free Survival
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
category
Medicine
Urology, Oncology
price
Free
Enzalutamide Plus Leuprolide Adds Up to ’Clinically Meaningful’ Benefit in Metastasis-Free Survival is organized by Projects In Knowledge Inc. (PIK).
Release Date: May 08, 2023
Termination Date: May 07, 2024
Activity Goal:
The goal of this CME/CE activity is to provide comprehensive and up-to-date information on the best practices in Prostate cancer
Learning Objective(s):
• Analyze clinical trial data regarding the efficacy of immunotherapies for the treatment of mCRPC.